Untermattweg 8
Bern 3027
Switzerland
41 58 852 81 11
https://www.galenica.com
Settore/i:
Settore:
Impiegati a tempo pieno: 5.517
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Marc Werner | Chief Exec. Officer | 1,24M | N/D | 1967 |
Mr. Felix Burkhard | CFO & Head of Investor Relations | N/D | N/D | 1966 |
Ms. Barbara Walchli | Gen. Counsel & Gen. Sec. | N/D | N/D | N/D |
Ms. Christina Hertig | Head of Corp. Communications | N/D | N/D | N/D |
Dr. Thomas F. Szuran | Chief Products & Marketing Officer | N/D | N/D | 1967 |
Ms. Marianne Ellenberger | Head of HR | N/D | N/D | 1963 |
Dr. Jörg Kneubühler | Advisor | N/D | N/D | 1960 |
Mr. Daniele Madonna | Chief Healthcare Officer | N/D | N/D | 1977 |
Mr. Andreas Koch | Head of Wholesale & Logistics | N/D | N/D | 1971 |
Ms. Virginie Pache Jeschka | Chief Pharmacies Officer | N/D | N/D | 1979 |
Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.
L'ISS Governance QualityScore di Galenica AG al 1 febbraio 2023 è 2. I criteri di valutazione fondamentali sono revisione: 1; Consiglio di Amministrazione: 3; diritti degli azionisti: 9; retribuzione: 2.